What We’re Watching: 2025 Third Quarter Results

While we wait for public orthopedic companies to announce 2025 third quarter results, we look back at the market’s first half performance, talk about expectations for foot and ankle volumes and look at companies like J&J MedTech, Smith+Nephew and CONMED that are trying to course correct.

Mike Evers is an analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage. You can reach him by email.

3 Additional Resources
Orthopedic Market Size and Share by Segment

Orthopedic Companies Sales Matrix

THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT®